Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.62 |
| ▸ | F7 | P08709 | 4/20 | 0.62 |
| ▸ | F3 | P13726 | 4/20 | 0.62 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.62 |
| ▸ | PPARD | Q03181 | 4/20 | 0.62 |
| ▸ | PPARA | Q07869 | 4/20 | 0.62 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.62 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.62 |
| ▸ | CASP6 | P55212 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | FABP4 | P15090 | 3/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28640562 | 0.99 | ALDH1A1 (0.63) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL28640561 | 0.99 | ALDH1A1 (0.63) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL31542088 | 0.95 | FFAR1 (0.65) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL31542094 | 0.95 | FFAR1 (0.65) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL14167279 | 0.93 | NFKB1 (0.67) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL28957396 | 0.91 | PPARG (0.64) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL14166621 | 0.90 | NFKB1 (0.60) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL28633230 | 0.90 | PPARG (0.65) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL14166620 | 0.90 | NFKB1 (0.60) | PPARGF7F3FFAR1PPARD | |
| SCHEMBL28633229 | 0.90 | PPARG (0.65) | PPARGF7F3FFAR1PPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215895-A1 | Therapeutic and carrier molecules | PEPLIN BIOLIPIDS PTY LTD (AU) | 2009-08-27 | — | — | US | disclosed |
| US-20090215895-A1 | Therapeutic and carrier molecules | PEPLIN BIOLIPIDS PTY LTD (AU) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215895-A1 | Therapeutic and carrier molecules | PHKG1, PHKG2, DGKB | PPARG 239/4885F7 3825/4885F3 595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.